Search Results
5 Results for 'Musculoskeletal'
PAGE 1 OF 1
Technology
Botulinum Neurotoxin A Subtype 6 And Pharmacological Methods Of Use
The invention is related to preparation of botulinum toxin A6 and methods of use.
Learn More
Learn More
Eric Johnson, Molly Moritz, Sabine Pellett, Marite Bradshaw, William Tepp | P180058US02
Technology
Novel Subtype of Botulinum Toxin for Prolonged Effectiveness
Clostridium botulinum produces botulinum neurotoxin (BoNT), which can cause debilitating disease but also is used to treat disorders like chronic headache, spastic muscles and strabismus.
Several di...
Learn More
Learn More
Eric Johnson, Mark Jacobson, Guangyun Lin, William Tepp, Raymond Stevens, Jerome Dupuy, Paul Stenmark | P09050US02
Technology
Hormone Analogs for Treating Hypoparathyroidism
The proper functioning of cells depends on information traveling from the extracellular environment to the cytoplasm. Most signals must be conveyed via proteins that span the cellular membrane. Many o...
Learn More
Learn More
Samuel Gellman, Ross Cheloha, Thomas Gardella | P130312US03
Technology
Vitamin D Analogs “WT-51” and “WT-52” Boost Bone and Skin Health
Vitamin D (1,25-dihydroxyvitamin D3) is a highly potent regulator of calcium homeostasis and plays an established role in cellular differentiation. An important class of vitamin D analogs, the 19-nor-...
Learn More
Learn More
Hector DeLuca, Lori Plum, Rafal Barycki, Margaret Clagett-Dame | P130007US02
Technology
Tat-Utrophin as a Protein Therapy for Muscular Dystrophies
No effective therapy currently exists for the most common and severe form of muscular dystrophy disease, Duchenne Muscular Dystrophy (DMD). This disease, which is characterized by the weakening of vol...
Learn More
Learn More
James Ervasti, Kevin Sonnemann | P06414US